October 29, 2019
Strongbridge Biopharma plc to Host Third Quarter 2019 Financial Results Conference Call on November 7, 2019
Media
October 29, 2019
Targovax ASA: Invitation to presentation of Targovax’s third quarter 2019 results, Thursday 7 November
October 24, 2019
Orexo Interim Report Q3 2019
October 22, 2019
GenSight Biologics Reports its Cash Position as of September 30, 2019 and Provides Operational Update
October 18, 2019
Nordic Nanovector – Private placement successfully completed
October 17, 2019
Strongbridge Biopharma plc Presents KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis (PPP) Data at the 2019 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting
October 09, 2019
Nordic Nanovector Presentations at the Annual Congress of the European Association of Nuclear Medicine (EANM)
October 09, 2019
GenSight Biologics reports evidence of GS010 DNA transfer to contralateral eye of primates unilaterally injected with GS010 Gene Therapy
October 09, 2019
Targovax selected for oral presentation at Society for Immunotherapy of Cancer (SITC) 2019 Annual Meeting
October 08, 2019
Camel-IDS appoints Ruggero Della Bitta MD, PhD, as Chief Medical Officer
